Why the study?
Comorbidities increase mortality in congestive heart failure, and it was unknown whether the DANCAMI could discriminate mortality in patients with heart failure.
Does the DANCAMI improve mortality prediction in patients with heart failure compared to baseline models or other comorbidity indices?
Does the DANCAMI improve mortality prediction in patients with heart failure compared to baseline models or other comorbidity indices?
Answers are grounded in this paper and cite their sources.
Adding the DANCAMI to age and sex improves the prediction of short- and long-term all-cause mortality, but not cardiovascular mortality, in patients with heart failure.
BACKGROUND: Patients with congestive heart failure (HF) are often burdened with comorbidities that increase mortality. Comorbidity indices provide a standardised method to measure comorbidity burden and predict prognosis. We aimed to investigate whether the Danish Comorbidity Index for Acute Myocardial Infarction (DANCAMI) can discriminate mortality in patients with HF. METHODS: = 311,628). We used logistic regression to calculate the area under the receiver operating characteristic curve (AUC) for cardiovascular and all-cause mortality within 30 days, 1 year, and 10 years of diagnosis. The AUCs were computed for a model including age and sex (baseline) and models also including the DANCAMI, the Charlson Comorbidity Index (CCI), or the Elixhauser Comorbidity Index (ECI). RESULTS: For all-cause mortality, the AUCs were higher for the DANCAMI than for the baseline model (30-day: 0.688 vs. 0.662; 1-year: 0.715 vs. 0.680; 10-year: 0.840 vs. 0.810). For cardiovascular mortality, the AUCs were comparable between the DANCAMI and the baseline model (30-day: 0.683 vs. 0.676; 1-year: 0.690 vs. 0.684; 10-year: 0.659 vs. 0.658). For both 30-day, 1-year, and 10-year all-cause and cardiovascular mortality, the AUCs for the CCI and the ECI were comparable to those for the DANCAMI. CONCLUSIONS: Adding the DANCAMI to a model including patient age and sex improved discrimination of short and long-term all-cause mortality but not of cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
Sikandar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: